This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Report of 16 Cases

Rufus J. Mark, MD; Jeffrey W. Bailet, MD; Luu M. Tran, MD; Joseph Poen, MD; Yao S. Fu, MD; Thomas C. Calcaterra, MD

Arch Otolaryngol Head Neck Surg. 1993;119(8):891-896.

Abstract
• Dermatofibrosarcoma protuberans of the head and neck is a rare neoplasm. Overall, sarcomas account for less than 1% of all head and neck malignancies. Of 229 patients with sarcomas of the head and neck seen at our institution between 1955 and 1988, 14 (7%) were assigned the diagnosis of dermatofibrosarcoma protuberans after pathologic review. Two additional cases have been seen since 1988, bringing the total to 16. All cases were low-grade lesions. Follow-up ranged from 36 to 198 months, with a median of 114 months. Fifteen patients were managed with surgery alone, and nine (60%) developed local recurrence. Eight were salvaged with further surgery. There were no regional lymph node recurrences or distant metastases. One patient was judged to be a poor surgical candidate and received primary radiation therapy. He died disease free 3 years after treatment. At last follow-up, 15 (94%) of 16 patients were ultimately disease free after salvage treatment. The overall 5-year survival rate was 93% (13/14). We conclude from this series, and from a review of the literature, that wide surgical resection achieving good margins offers excellent probability of cure, and that radiation therapy is a reasonable alternative in patients who have unresectable lesions or who are medically inoperable.

(Arch Otolaryngol Head Neck Surg. 1993;119:891-896)

Author Affiliations
From the Radiation Medical Group, San Diego, Calif (Dr Mark), and the Departments of Surgery (Division of Head and Neck Surgery) (Drs Bailet and Calcaterra), Radiation Oncology (Drs Tran and Poen), and Pathology (Dr Fu), UCLA Medical Center.

Footnotes
Accepted for publication December 11, 1992.

Presented in part at the annual meeting of the American College of Surgery, Southern California Chapter, Indian Wells, Calif, January 18, 1992.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neoadjuvant Imatinib Therapy for Dermatofibrosarcoma Protuberans
Han et al.
Arch Dermatol 2009;145:792-796.
ABSTRACT | FULL TEXT  

Molecular and Clinical Analysis of Locally Advanced Dermatofibrosarcoma Protuberans Treated With Imatinib: Imatinib Target Exploration Consortium Study B2225
McArthur et al.
JCO 2005;23:866-873.
ABSTRACT | FULL TEXT  

Multispecialty Approach to Complex Dermatofibrosarcoma Protuberans of the Forehead
Haas and Sykes
Arch Otolaryngol Head Neck Surg 1998;124:324-327.
ABSTRACT | FULL TEXT  

Effect of Resection Margins on Dermatofibrosarcoma Protuberans of the Head and Neck
Gayner et al.
Arch Otolaryngol Head Neck Surg 1997;123:430-433.
ABSTRACT